Manufacturing Establishments (1)
Breckenridge Pharmaceutical, Inc.
117549200
Products (1)
Butalbital, Acetaminophen, Caffeine and Codeine Phosphate
51991-073
ANDA076560
ANDA (C73584)
ORAL
October 31, 2023
Drug Labeling Information
RECENT MAJOR CHANGES SECTION
RECENT MAJOR CHANGES
Dosage and Administration (2.2) |
03/2021 |
Warnings and Precautions (5.1, 5.3, 5.4) |
03/2021 |
DOSAGE FORMS & STRENGTHS SECTION
Highlight: * Capsules: 50 mg butalbital, 325 mg acetaminophen, 40 mg caffeine, and 30 mg codeine phosphate.
3 DOSAGE FORMS AND STRENGTHS
Capsules: Butalbital 50 mg, Acetaminophen 325 mg, Caffeine 40 mg, Codeine Phosphate 30 mg
Blue, opaque cap with a gray, opaque body, and body is imprinted with "B073" in black ink.
CONTRAINDICATIONS SECTION
Highlight: * Children younger than 12 years of age. (4)
- Post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy. (4)
- Significant respiratory depression. (4)
- Acute or severe bronchial asthma in an unmonitored setting or in absence of resuscitative equipment. (4)
- Concurrent use of monoamine oxidase inhibitors (MAOIs) or use of MAOIs within the last 14 days. (4)
- Known or suspected gastrointestinal obstruction, including paralytic ileus. (4)
- Intolerance or hypersensitivity to acetaminophen, caffeine, butalbital or codeine, or components of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. (4)
- Porphyria. (4)
4 CONTRAINDICATIONS
Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules are contraindicated for:
- All children younger than 12 years of age [see Warnings and Precautions (5.5)].
- Post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy [see Warnings and Precautions (5.5)].
Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules are also contraindicated in patients with:
- Significant respiratory depression [see Warnings and Precautions (5.3)]
- Acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see Warnings and Precautions (5.9)]
- Concurrent use of monoamine oxidase inhibitors (MAOIs) or use of MAOIs within the last 14 days [see Warnings and Precautions (5.10), Drug Interactions (7)]
- Known or suspected gastrointestinal obstruction, including paralytic ileus [see Warnings and Precautions (5.14)]
- Known intolerance or hypersensitivity to acetaminophen, caffeine, butalbital, or codeine or to the components of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules
- Porphyria
BOXED WARNING SECTION
**WARNING: ADDICTION, ABUSE, AND MISUSE; RISK EVALUATION AND MITIGATION
STRATEGY (REMS); LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS; ULTRA-RAPID METABOLISM OF CODEINE AND OTHER RISK FACTORS FOR LIFE-THREATENING RESPIRATORY DEPRESSION IN CHILDREN; NEONATAL OPIOID WITHDRAWAL SYNDROME; INTERACTIONS WITH DRUGS AFFECTING CYTOCHROME P450 ISOENZYMES; and HEPATOTOXICITY**
SPL MEDGUIDE SECTION
Medication Guide
Dispense with Medication Guide available at: www.bpirx.com/products/patientinformation
Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules, C III |
Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules are:
|
Important information about Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules: *Get emergency help or call 911 right away if you take too much Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules (overdose). When you first start taking Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules, when your dose is changed, or if you take too much (overdose), serious or life-threatening breathing problems that can lead to death may occur. Talk to your healthcare provider about naloxone, a medicine for the emergency treatment of an opioid overdose.
|
Important Information Guiding Use in Pediatric Patients:
|
Do not take Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules if you have:
|
Before taking Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules, tell your healthcare provider if you have a history of:
Tell your healthcare provider if you are: *pregnant or planning to become pregnant. Prolonged use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules, during pregnancy can cause withdrawal symptoms in your newborn baby that could be life-threatening if not recognized and treated. *breastfeeding. Not recommended; may harm your baby.
|
When taking Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules:
|
While taking Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules DO NOT:
|
The possible side effects of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules:
Get emergency medical help or call 911 right away if you:
These are not all the possible side effects of Butalbital, Acetaminophen,
Caffeine, and Codeine Phosphate Capsules. Call your doctor for medical advice
about side effects. You may report side effects to FDA at 1-800-FDA-1088.
For more information go to dailymed.nlm.nih.gov |
This Medication Guide has been approved by the U.S. Food and Drug Administration.
6670
Rev. 10/2023
SPL UNCLASSIFIED SECTION
Dispense with Medication Guide available at: www.bpirx.com/products/patientinformation
Manufactured by:
LGM Pharma Solutions, LLC
Irvine, CA 92614
Manufactured for:
Breckenridge Pharmaceutical, Inc.
Berkeley Heights, NJ 07922
6670
Rev. 10/2023